Last Updated:

Thursday, March 4, 2021

12:31 AM

Canada

Algernon Pharmaceuticals

Algernon Pharmaceuticals is a clinical-stage pharmaceutical development company focused on the areas of non–alcoholic steatohepatitis (NASH), chronic kidney disease (CKD), inflammatory bowel disease (IBD) and idiopathic pulmonary fibrosis (IPF).